Trial Profile
ViaDerm-calcitonin for the treatment of musculoskeletal disorders.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Jan 2011
Price :
$35
*
At a glance
- Drugs Calcitonin (Primary) ; Calcitonin
- Indications Osteoarthritis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors TransPharma Medical
- 12 Jan 2011 Results were reported in a TransPharma media release.
- 12 Jan 2011 New trial record